Médicos de Biópsia no exterior — Página 12

O médico é um especialista em radioterapia e oncologista altamente qualificado com ampla experiência no tratamento de vários tipos de câncer. Especializando-se em técnicas avançadas de radioterapia, o médico contribuiu significativamente para melhorar os resultados dos pacientes através de planos de tratamento inovadores. O médico é acreditado por conselhos médicos líderes e publicou numerosos artigos de pesquisa em revistas médicas de prestígio, enriquecendo o campo da oncologia com descobertas inovadoras.<\/p>

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Paul Stanciu is the first gynecologist worldwide accredited to operate on two different robotic platforms. He specializes in gynecological oncology and robotic surgery at Ponderas Academic Hospital. Dr. Stanciu trained at renowned centers including The Royal Marsden Hospital in the UK.

• Holds certifications from SERGS, ESGO, BSCCP, and IOTA.
• Performs complex procedures for endometriosis and fertility-sparing cancer surgery.
• Delivered over 100 presentations at national and international medical conferences.
• Works at a JCI-accredited hospital designated as a Robotic Surgery Center of Excellence.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

O médico é um oncocirurgião altamente experiente, com foco em técnicas cirúrgicas avançadas para o tratamento do câncer. Com ampla experiência na área, o médico contribuiu significativamente para o desenvolvimento de protocolos cirúrgicos inovadores destinados a melhorar os resultados dos pacientes. O médico é reconhecido por sua dedicação à excelência clínica e publicou numerosos artigos de pesquisa em revistas médicas de prestígio. Como professor, o médico está ativamente envolvido na educação da próxima geração de cirurgiões, enfatizando a importância da precisão e do cuidado centrado no paciente na oncocirurgia.<\/p>

Dr. Shady Mohammed El-sebai is the Chief of Interventional Radiology at the National Cancer Institute, Cairo University. He specializes in oncology-focused imaging and minimally invasive procedures. Dr. El-sebai treats liver, renal, and soft-tissue tumors using chemoembolization and ablation techniques. He works at Shef Al Orman Oncology Hospital, an ESMO-accredited center.

• Performs microwave and radiofrequency ablation for bone, lung, and thyroid lesions.
• Expert in US- and CT-guided biopsies, including Mammotome breast lesion excision.
• Specializes in uterine artery embolization for fibroids and varicose vein ablation.
• Manages complex biliary and renal cases with percutaneous stenting and drainage.

O médico é um oncocirurgião distinto com ampla experiência em urologia. Especializando-se em técnicas cirúrgicas avançadas, o médico contribuiu significativamente para o campo da oncologia urológica. Com foco em procedimentos minimamente invasivos, o médico realizou com sucesso inúmeras cirurgias complexas, melhorando os resultados dos pacientes. O médico também está ativamente envolvido em pesquisa clínica, contribuindo para várias publicações revisadas por pares e apresentando descobertas em conferências internacionais.<\/p>

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Dr. Doyoung Jeong is an obstetrician-gynecologist at Seoul Miz Hospital. He specializes in single-port robotic and minimally invasive surgery for uterine and ovarian diseases. Dr. Jeong holds multiple patents for specialized single-port surgical devices. He is a full member of the International Society of Ultrasound in Obstetrics and Gynecology.

• Served as Director and Chief Medical Officer at Incheon Sejong Hospital.
• Former Vice President at Dongtan Jeil Hospital.
• Clinical Professor at Kyung Hee University Hospital and Adjunct Professor at Korea University.
• Acts as a clinical medical device expert for the Ministry of Food and Drug Safety.